Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 10Sanofi
02 1Biophore India Pharmaceuticals Pvt Ltd
03 2Dr. Reddy's Laboratories
04 1NanoAlvand
05 1Supriya Lifescience
06 3Accord healthcare
07 1Amneal Pharmaceuticals
08 2Arrotex Pharmaceuticals
09 1Aurobindo Pharma Limited
10 2EUGIA PHARMA (AUSTRALIA) PTY LTD
11 1EUGIA PHARMA INC.
12 1Eugia Pharma
13 1GLAND PHARMA LIMITED
14 1Glenmark Pharmaceuticals
15 2Hetero Drugs
16 1JAMP PHARMA
17 1MSN Laboratories
18 1Meitheal Pharmaceuticals
19 1Naprod Life Sciences
20 1ORIFARM GROUP AS
21 3SEACROSS PHARMACEUTICALS
22 1STADA Arzneimittel
23 1Tarbis Farma Sl
24 2Teva Pharmaceutical Industries
25 1Tillomed Laboratories Ltd
26 1Viatris
27 1Vivanta Generics Sro
28 1Zydus Pharmaceuticals
01 2INJ
02 15Injectable Solution
03 3Injection
04 2Injection fluid, resolution
05 1Liquid Injection
06 1Plerixafor 24Mg 1,2Ml 1 Unit Parenteral Use
07 3SOLUTION
08 10SOLUTION;SUBCUTANEOUS
09 2Solution for injection
10 1Vial
11 6Blank
01 1Allowed
02 6Approved
03 8Authorized
04 1DISCN
05 1Generic
06 1Lead Market Dossiers- Filed
07 1Originator
08 3Prescription
09 9RX
10 15Blank
01 1Heterix 24
02 2MOZOBIL
03 9Mozobil
04 1Neofor
05 9PLERIXAFOR
06 2PLERIXAFOR EUGIA
07 2PLERIXAFOR INJECTION
08 1Plerazafor Accord
09 2Plerixafor ARX
10 2Plerixafor Accord
11 1Plerixafor Eugia
12 1Plerixafor Glenmark
13 3Plerixafor Seacross
14 1Plerixafor Stada
15 1Plerixafor Tarbis
16 1Plerixafor Teva
17 1Plerixafor Tillomed
18 1Plerixafor Viatris
19 1Plerixafor Vivanta
20 4Blank
01 6Australia
02 3Canada
03 4India
04 1Iran
05 1Italy
06 4Norway
07 2South Africa
08 8Spain
09 6Sweden
10 1Switzerland
11 10USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : RX
Registration Country : USA
Brand Name : MOZOBIL
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 24MG/1.2ML (20MG/ML)
Packaging :
Approval Date : 2008-12-15
Application Number : 22311
Regulatory Info : RX
Registration Country : USA
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 24MG/1.2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : PLERIXAFOR
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 24MG/1.2ML (20MG/ML)
Packaging :
Approval Date : 2023-07-24
Application Number : 205182
Regulatory Info : RX
Registration Country : USA
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Neofor
Dosage Form : Vial
Dosage Strength : 24MG/1.2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 24MG/1.2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Mozobil
Dosage Form : Plerixafor 24Mg 1,2Ml 1 Unit Parenteral Use
Dosage Strength : 1 bottle SC 24 mg 20 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Norway
Brand Name : Mozobil
Dosage Form : Injection fluid, resolution
Dosage Strength : 20 mg/ml
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Mozobil
Dosage Form : Injectable Solution
Dosage Strength : 20mg/ml
Packaging :
Approval Date : 15/08/2014
Application Number : 63139
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Mozobil
Dosage Form : Injectable Solution
Dosage Strength : 20mg/ml
Packaging :
Approval Date : 31/07/2009
Application Number : 20080608000019
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : MOZOBIL
Dosage Form : SOLUTION
Dosage Strength : 20MG/ML
Packaging : 1.2ML
Approval Date :
Application Number : 2377225
Regulatory Info : Prescription
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Mozobil
Dosage Form : INJ
Dosage Strength : 20mg/ml
Packaging : 1.2X1mg/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Australia
Brand Name : Mozobil
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Australia
Brand Name : Mozobil
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Mozobil
Dosage Form : Injectable Solution
Dosage Strength : 20MG
Packaging :
Approval Date : 2009-11-12
Application Number : 09537001
Regulatory Info : Authorized
Registration Country : Spain
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 20MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : PLERIXAFOR
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 24MG/1.2ML (20MG/ML)
Packaging :
Approval Date : 2023-07-24
Application Number : 213672
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PLERIXAFOR
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 24MG/1.2ML (20MG/ML)
Packaging :
Approval Date : 2024-05-03
Application Number : 206644
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PLERIXAFOR
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 24MG/1.2ML (20MG/ML)
Packaging :
Approval Date : 2023-07-24
Application Number : 211901
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PLERIXAFOR
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 24MG/1.2ML (20MG/ML)
Packaging :
Approval Date : 2023-07-24
Application Number : 205197
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PLERIXAFOR
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 24MG/1.2ML (20MG/ML)
Packaging :
Approval Date : 2023-07-26
Application Number : 208980
Regulatory Info : DISCN
Registration Country : USA
